GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Devonian Health Group Inc (TSXV:GSD) » Definitions » Price-to-Free-Cash-Flow

Devonian Health Group (TSXV:GSD) Price-to-Free-Cash-Flow : 3.27 (As of May. 23, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Devonian Health Group Price-to-Free-Cash-Flow?

As of today (2025-05-23), Devonian Health Group's share price is C$0.16. Devonian Health Group's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jan. 2025 was C$0.05. Hence, Devonian Health Group's Price-to-Free-Cash-Flow Ratio for today is 3.27.

The historical rank and industry rank for Devonian Health Group's Price-to-Free-Cash-Flow or its related term are showing as below:

TSXV:GSD' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 2.2   Med: 4   Max: 5.1
Current: 3.27

During the past 11 years, Devonian Health Group's highest Price-to-Free-Cash-Flow Ratio was 5.10. The lowest was 2.20. And the median was 4.00.

TSXV:GSD's Price-to-Free-Cash-Flow is ranked better than
95.09% of 224 companies
in the Biotechnology industry
Industry Median: 31.2 vs TSXV:GSD: 3.27

Devonian Health Group's Free Cash Flow per Share for the three months ended in Jan. 2025 was C$-0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was C$0.05.

During the past 11 years, Devonian Health Group's highest 3-Year average Free Cash Flow per Share Growth Rate was 41.90% per year. The lowest was -22.60% per year. And the median was 5.55% per year.


Devonian Health Group Price-to-Free-Cash-Flow Historical Data

The historical data trend for Devonian Health Group's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devonian Health Group Price-to-Free-Cash-Flow Chart

Devonian Health Group Annual Data
Trend Jun15 Jun16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 4.87

Devonian Health Group Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 4.87 2.29 3.47

Competitive Comparison of Devonian Health Group's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Devonian Health Group's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Devonian Health Group's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Devonian Health Group's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Devonian Health Group's Price-to-Free-Cash-Flow falls into.


;
;

Devonian Health Group Price-to-Free-Cash-Flow Calculation

Devonian Health Group's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.16/0.049
=3.27

Devonian Health Group's Share Price of today is C$0.16.
Devonian Health Group's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.05.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Devonian Health Group  (TSXV:GSD) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Devonian Health Group Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Devonian Health Group's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Devonian Health Group Business Description

Traded in Other Exchanges
Address
360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.

Devonian Health Group Headlines

No Headlines